European Journal of Surgical Oncology
Volume 34, Issue 11 , Pages 1231-1236 , November 2008

Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases

  • S. Kandutsch

      Affiliations

    • Clinical Institute of Pathology, Vienna General Hospital, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • Contributed equally to this work.
    • ,
  • M. Klinger

      Affiliations

    • Department of General Surgery, Hepatobiliary Service, Vienna General Hospital, Medical University Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 1 40400 5621; fax: +43 1 40400 6932.
    • Contributed equally to this work.
    • ,
  • S. Hacker

      Affiliations

    • Department of General Surgery, Hepatobiliary Service, Vienna General Hospital, Medical University Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria
    • ,
  • F. Wrba

      Affiliations

    • Clinical Institute of Pathology, Vienna General Hospital, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    • ,
  • B. Gruenberger

      Affiliations

    • Internal Medicine I, Department of Oncology, Rudolfstiftung Hospital, Juchgasse 25, A-1030 Vienna, Austria
    • ,
  • T. Gruenberger

      Affiliations

    • Department of General Surgery, Hepatobiliary Service, Vienna General Hospital, Medical University Vienna, Waehringer Guertel 18–20, A-1090 Vienna, Austria

,Accepted 2 January 2008.

References 

  1. Hwang PM, Bunz F, Yu J, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med. 2001;7:1111–1117
  2. Laurent A, Nicco C, Chereau C, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005;65:948–956
  3. Kohli R, Pan X, Malladi P, et al. Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway. J Biol Chem. 2007;282:21327–21336
  4. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–923
  5. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  6. Fong Y, Bentrem DJ. CASH (chemotherapy-associated steatohepatitis) costs. Ann Surg. 2006;243:8–9
  7. Zorzi D, Laurent A, Pawlik TM, et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274–286
  8. Zeiss J, Merrick HW, Savolaine ER, et al. Fatty liver change as a result of hepatic artery infusion chemotherapy. Am J Clin Oncol. 1990;13:156–160
  9. Peppercorn PD, Reznek RH, Wilson P, et al. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer. 1998;77:2008–2011
  10. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003;7:1034–1044
  11. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22:27–42
  12. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol. 2004;15:460–466
  13. Pawlik TM, Olino K, Gleisner AL, et al. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007;11:860–868
  14. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–2947
  15. Bismuth H, Adam R. Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy. Semin Oncol. 1998;25:40–46
  16. Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg. 2003;7:109–115
  17. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg. 2004;240:1052–1061
  18. Tanaka K, Adam R, Shimada H, et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg. 2003;90:963–969
  19. Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005;200:845–853
  20. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983–4990
  21. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065–2072
  22. Kakar S, Kamath PS, Burgart LJ. Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?. Arch Pathol Lab Med. 2004;128:901–904
  23. Wild R, Dings RP, Subramanian I, Ramakrishnan S. Carboplatin selectively induces the VEGF stress response in endothelial cells: potentiation of antitumor activity by combination treatment with antibody to VEGF. Int J Cancer. 2004;110:343–351
  24. Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol (Meeting Abstracts). 2007;25:LBA5

PII: S0748-7983(08)00002-4

doi: 10.1016/j.ejso.2008.01.001

European Journal of Surgical Oncology
Volume 34, Issue 11 , Pages 1231-1236 , November 2008

Article Tools

* Image Usage & Resolution